Granulomatous Slack Skin
Watchlist
Retrieved
2021-01-18
Source
Trials
—
Genes
—
Drugs
A-dmDT390-bisFv(UCHT1),
Adenovirus-Interferon gamma - coding DNA sequence,
Alisertib,
Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus,
Belinostat
(
BELEODAQ
),
Brentuximab vedotin
(
ADCETRIS
),
Chlormethine
(
Ledaga
),
Darinaparsin,
Denileukin diftitox,
Fenretinide,
Forodesine hydrochloride,
Human monoclonal antibody against CD4,
Humanised IgG1 monoclonal antibody against human KIR3DL2,
Iodine (131I) tositumomab,
Meclorethamine
(
VALCHLOR
),
Miltefosine
(
IMPAVIDO
),
Mogamulizumab
(
POTELIGEO
),
N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide,
Naloxone hydrochloride dihydrate,
Panobinostat
(
FARYDAK
),
Pralatrexate
(
FOLOTYN
),
Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein,
Resiquimod,
Romidepsin
(
ISTODAX
),
Siplizumab,
Suberolylanilide hydroxamic acid,
Synthetic hypericin,
Vorinostat
(
ZOLINZA
),
Zanolimumab,
haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate
Registered!
Granulomatous slack skin (GSS) is a rare cutaneous condition, a variant of lymphoma that typically presents in middle-aged adults.:735
It is a form of cutaneous T-cell lymphoma and a variant of mycosis fungoides.
See also
- List of cutaneous conditions